[Form 4] DocuSign, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Mary Agnes Wilderotter, a director of DocuSign, Inc. (DOCU), received a grant of 729 restricted stock units (RSUs) on 08/29/2025. Each RSU converts to one share of common stock when vested. After the grant, the filing reports 58,345 shares beneficially owned by Ms. Wilderotter in common stock and 2,187 RSUs beneficially owned in derivative form. The RSUs have a vest commencement date of May 29, 2025 and vest in equal quarterly installments over one year, with the fourth installment potentially accelerating to the earlier of the next annual meeting or the one-year anniversary, subject to continued service. The RSUs do not expire and are either vested or canceled prior to vesting.

Positive

• Director grant documented: 729 RSUs were granted on 08/29/2025, showing transparent insider compensation reporting.
• Clear vesting terms: RSUs vest quarterly over one year starting 05/29/2025 with potential acceleration for the fourth installment.
• Non-expiring RSUs: The RSUs do not expire and will either vest or be canceled, simplifying vesting outcome.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Director received a time‑based RSU grant with quarterly vesting and potential acceleration tied to service and the next annual meeting.

The grant is a routine, service‑based equity award commonly used to align board members with shareholder interests. Vesting commences May 29, 2025 and occurs quarterly over one year, with the fourth installment eligible for earlier vesting at the company’s next annual meeting or one‑year anniversary. The RSUs are non‑expiring until vested or forfeited, which simplifies administrative treatment. This disclosure is procedural and does not indicate any change in control terms or performance conditions.

Securities Analyst

TL;DR: The filing documents a small director grant increasing reported beneficial holdings to 58,345 shares and 2,187 RSUs.

The transaction shows acquisition code 'M' for 729 RSUs on 08/29/2025 and updates post‑transaction holdings. The size of the grant (729 RSUs) appears modest relative to typical board compensation bands for public companies; the filing does not disclose dollar value or any sale/transfer activity. No derivative exercise prices or expiration dates apply because these are RSUs. Impact on share count or dilution is not provided in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wilderotter Mary Agnes

(Last) (First) (Middle)

C/O DOCUSIGN, INC.

221 MAIN STREET, SUITE 800

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DOCUSIGN, INC. [ DOCU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/29/2025		M		729	A	$0	58,345	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	08/29/2025		M			729	(2)	(3)	Common Stock	729	$0	2,187	D

Explanation of Responses:

1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

2. The RSUs have a vest commencement date of May 29, 2025 and will vest in equal quarterly installments over one year, provided that the fourth quarterly installment shall vest in full on the earlier of (i) the date of the Company's next annual meeting of stockholders and (ii) the one year anniversary of the grant, in each case, subject to the Reporting Person being a service provider through each such date.

3. The RSUs do not expire; they either vest or are canceled prior to vesting date.

Remarks:

	/s/ Derrick Chapman, Attorney-in-fact	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did DOCU director Mary Agnes Wilderotter receive on 08/29/2025?

She was granted 729 restricted stock units (RSUs) on 08/29/2025 according to the Form 4.

How many DocuSign shares does Mary Agnes Wilderotter beneficially own after the transaction?

The Form 4 reports 58,345 shares of common stock beneficially owned following the reported transaction.

What are the vesting terms for the RSUs granted to the DOCU director?

Vesting begins on May 29, 2025 and occurs in equal quarterly installments over one year; the fourth installment may vest earlier at the company’s next annual meeting or the one‑year anniversary, subject to service.

Do the RSUs granted to the DOCU director expire?

No; the filing states the RSUs do not expire and will either vest or be canceled prior to vesting.

How many RSUs does the filing report as beneficially owned after the grant?

The Form 4 shows 2,187 RSUs beneficially owned following the reported transaction(s).